HPC Offered for PRESERVE Expansion

Recruiting now

Conditions studied: Bone Marrow Transplant (BMT)

In brief

Ossium recognizes that not all patients who could benefit from Ossium's HPC, Marrow can access the PRESERVE trial for logistical or eligibility reasons. The HOPE program is expanded access program to serve these patients by providing our bone marrow product

Key facts

Study ID

NCT07145411

Run by

Ossium Health, Inc.

People needed

10

Starts

2024-06-27

Expected to finish

2029-08-01

Last updated by the study team

2025-08-28

Who can join

Age: 12 and older, up to 80. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Patients aged 12-80 may be eligible* to receive bone marrow for transplantation through the Ossium HOPE Program if:
• Their treating physician determined they are eligible for allogeneic bone marrow transplant Their treating physician determined that the potential benefit outweighs the potential risks

Where it is running

• University of Alabama, Birmingham — Birmingham, Alabama, United States (enrolling)
• Henry Ford Health — Detroit, Michigan, United States (enrolling)
• The Ohio State University Medical Center — Columbus, Ohio, United States (enrolling)
• Tristar Centennial Medical Center — Nashville, Tennessee, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.